• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

索利那新([(3R)-1-氮杂双环[2.2.2]辛烷-3-基](1S)-1-苯基-3,4-二氢-1H-异喹啉-2-甲酰胺)激活 M 型钾电流的有效性:与其抗毒蕈碱作用无关。

The Effectiveness in Activating M-Type K Current Produced by Solifenacin ([(3R)-1-azabicyclo[2.2.2]octan-3-yl] (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate): Independent of Its Antimuscarinic Action.

机构信息

Department of Physiology, National Cheng Kung University Medical College, Tainan City 70101, Taiwan.

Institute of Basic Medical Sciences, National Cheng Kung University Medical College, Tainan City 70101, Taiwan.

出版信息

Int J Mol Sci. 2021 Nov 17;22(22):12399. doi: 10.3390/ijms222212399.

DOI:10.3390/ijms222212399
PMID:34830281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8622881/
Abstract

Solifenacin (Vesicare, SOL), known to be a member of isoquinolines, is a muscarinic antagonist that has anticholinergic effect, and it has been beneficial in treating urinary incontinence and neurogenic detrusor overactivity. However, the information regarding the effects of SOL on membrane ionic currents is largely uncertain, despite its clinically wide use in patients with those disorders. In this study, the whole-cell current recordings revealed that upon membrane depolarization in pituitary GH cells, the exposure to SOL concentration-dependently increased the amplitude of M-type K current (I) with effective EC value of 0.34 μM. The activation time constant of I was concurrently shortened in the SOL presence, hence yielding the K value of 0.55 μM based on minimal reaction scheme. As cells were exposed to SOL, the steady-state activation curve of I was shifted along the voltage axis to the left with no change in the gating charge of the current. Upon an isosceles-triangular ramp pulse, the hysteretic area of I was increased by adding SOL. As cells were continually exposed to SOL, further application of acetylcholine (1 μM) failed to modify SOL-stimulated I; however, subsequent addition of thyrotropin releasing hormone (TRH, 1 μM) was able to counteract SOL-induced increase in I amplitude. In cell-attached single-channel current recordings, bath addition of SOL led to an increase in the activity of M-type K (K) channels with no change in the single channel conductance; the mean open time of the channel became lengthened. In whole-cell current-clamp recordings, the SOL application reduced the firing of action potentials (APs) in GH cells; however, either subsequent addition of TRH or linopirdine was able to reverse SOL-mediated decrease in AP firing. In hippocampal mHippoE-14 neurons, the I was also stimulated by adding SOL. Altogether, findings from this study disclosed for the first time the effectiveness of SOL in interacting with K channels and hence in stimulating I in electrically excitable cells, and this noticeable action appears to be independent of its antagonistic activity on the canonical binding to muscarinic receptors expressed in GH or mHippoE-14 cells.

摘要

索利那新(Vesicare,SOL)是一种异喹啉类化合物,属于毒蕈碱拮抗剂,具有抗胆碱能作用,已被证明可有效治疗尿失禁和神经源性逼尿肌过度活动症。然而,尽管 SOL 在这些疾病的患者中广泛使用,但关于其对膜离子电流影响的信息仍然很大程度上不确定。在这项研究中,全细胞膜电流记录显示,在 GH 细胞的膜去极化时,暴露于 SOL 浓度依赖性地增加了 M 型钾电流(I)的幅度,有效 EC 值为 0.34 μM。在 SOL 存在的情况下,I 的激活时间常数同时缩短,因此根据最小反应方案得出 K 值为 0.55 μM。当细胞暴露于 SOL 时,I 的稳态激活曲线沿电压轴向左移位,而电流的门控电荷不变。在等腰三角形斜坡脉冲下,加入 SOL 会增加 I 的滞后面积。当细胞持续暴露于 SOL 时,进一步应用乙酰胆碱(1 μM)无法改变 SOL 刺激的 I;然而,随后加入促甲状腺素释放激素(TRH,1 μM)能够抵消 SOL 诱导的 I 幅度增加。在细胞贴附式单通道电流记录中,浴液中加入 SOL 导致 M 型钾(K)通道的活性增加,而单通道电导不变;通道的平均开放时间延长。在全细胞膜电流钳记录中,应用 SOL 会减少 GH 细胞中动作电位(AP)的发放;然而,随后加入 TRH 或利诺吡啶能够逆转 SOL 介导的 AP 发放减少。在海马 mHippoE-14 神经元中,加入 SOL 也可刺激 I。总之,这项研究首次揭示了 SOL 与 K 通道相互作用并刺激电兴奋细胞中 I 的有效性,这种明显的作用似乎与其在 GH 或 mHippoE-14 细胞中对经典毒蕈碱受体的拮抗活性无关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0af/8622881/7a737f8c1cf7/ijms-22-12399-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0af/8622881/8ae52e71c87d/ijms-22-12399-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0af/8622881/10c0cef28533/ijms-22-12399-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0af/8622881/02116946d203/ijms-22-12399-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0af/8622881/1842015ec355/ijms-22-12399-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0af/8622881/c553bc184b81/ijms-22-12399-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0af/8622881/1ace5283cf35/ijms-22-12399-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0af/8622881/03ce78135a6a/ijms-22-12399-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0af/8622881/ddb914db904c/ijms-22-12399-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0af/8622881/7a737f8c1cf7/ijms-22-12399-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0af/8622881/8ae52e71c87d/ijms-22-12399-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0af/8622881/10c0cef28533/ijms-22-12399-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0af/8622881/02116946d203/ijms-22-12399-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0af/8622881/1842015ec355/ijms-22-12399-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0af/8622881/c553bc184b81/ijms-22-12399-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0af/8622881/1ace5283cf35/ijms-22-12399-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0af/8622881/03ce78135a6a/ijms-22-12399-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0af/8622881/ddb914db904c/ijms-22-12399-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c0af/8622881/7a737f8c1cf7/ijms-22-12399-g009.jpg

相似文献

1
The Effectiveness in Activating M-Type K Current Produced by Solifenacin ([(3R)-1-azabicyclo[2.2.2]octan-3-yl] (1S)-1-phenyl-3,4-dihydro-1H-isoquinoline-2-carboxylate): Independent of Its Antimuscarinic Action.索利那新([(3R)-1-氮杂双环[2.2.2]辛烷-3-基](1S)-1-苯基-3,4-二氢-1H-异喹啉-2-甲酰胺)激活 M 型钾电流的有效性:与其抗毒蕈碱作用无关。
Int J Mol Sci. 2021 Nov 17;22(22):12399. doi: 10.3390/ijms222212399.
2
Effective Activation by Kynurenic Acid and Its Aminoalkylated Derivatives on M-Type K Current.色氨酸代谢产物犬尿氨酸及其氨烷基衍生物对 M 型钾电流的有效激活作用。
Int J Mol Sci. 2021 Jan 28;22(3):1300. doi: 10.3390/ijms22031300.
3
Concerted suppression of I and activation of I by ivabradine, an HCN-channel inhibitor, in pituitary cells and hippocampal neurons.异搏定(一种 HCN 通道抑制剂)对脑垂体细胞和海马神经元中 I 的协同抑制和激活。
Brain Res Bull. 2019 Jul;149:11-20. doi: 10.1016/j.brainresbull.2019.03.016. Epub 2019 Apr 3.
4
Evidence for Dual Activation of and Caused by QO-58 (5-(2,6-Dichloro-5-fluoropyridin-3-yl)-3-phenyl-2-(trifluoromethyl)-1H-pyrazolol[1,5-a]pyrimidin-7-one).证据表明 QO-58(5-(2,6-二氯-5-氟吡啶-3-基)-3-苯基-2-(三氟甲基)-1H-吡唑并[1,5-a]嘧啶-7-酮)能双重激活 和 。
Int J Mol Sci. 2022 Jun 24;23(13):7042. doi: 10.3390/ijms23137042.
5
Evidence for Inhibitory Perturbations on the Amplitude, Gating, and Hysteresis of A-Type Potassium Current, Produced by Lacosamide, a Functionalized Amino Acid with Anticonvulsant Properties.具有抗惊厥特性的功能化氨基酸拉科酰胺对 A 型钾电流的幅度、门控和滞后产生抑制性干扰的证据。
Int J Mol Sci. 2022 Jan 21;23(3):1171. doi: 10.3390/ijms23031171.
6
Characterization of Effectiveness in Concerted Inhibition and Stimulation by Pterostilbene (Trans-3,5-dimethoxy-4'-hydroxystilbene), a Stilbenoid.白藜芦醇(反式-3,5-二甲氧基-4'-羟基二苯乙烯)协同抑制和刺激作用的特性研究。
Int J Mol Sci. 2020 Jan 5;21(1):357. doi: 10.3390/ijms21010357.
7
Effects of Sesamin, the Major Furofuran Lignan of Sesame Oil, on the Amplitude and Gating of Voltage-Gated Na and K Currents.芝麻素,芝麻油中的主要呋喃木脂素,对电压门控钠和钾电流的幅度和门控的影响。
Molecules. 2020 Jul 4;25(13):3062. doi: 10.3390/molecules25133062.
8
Modulation of rat erg1, erg2, erg3 and HERG K+ currents by thyrotropin-releasing hormone in anterior pituitary cells via the native signal cascade.促甲状腺激素释放激素通过天然信号级联对大鼠垂体前叶细胞中erg1、erg2、erg3和HERG钾离子电流的调节作用。
J Physiol. 2001 Apr 1;532(Pt 1):143-63. doi: 10.1111/j.1469-7793.2001.0143g.x.
9
Bisoprolol, Known to Be a Selective β₁-Receptor Antagonist, Differentially but Directly Suppresses I and I in Pituitary Cells and Hippocampal Neurons.比索洛尔,已知为选择性β₁受体拮抗剂,直接但有差异地抑制脑垂体细胞和海马神经元中的 I 和 I。
Int J Mol Sci. 2019 Feb 2;20(3):657. doi: 10.3390/ijms20030657.
10
Inhibitory Effective Perturbations of Cilobradine (DK-AH269), A Blocker of HCN Channels, on the Amplitude and Gating of Both Hyperpolarization-Activated Cation and Delayed-Rectifier Potassium Currents.HCN通道阻滞剂西洛他定(DK-AH269)对超极化激活阳离子电流和延迟整流钾电流的幅度及门控的抑制性有效扰动
Int J Mol Sci. 2020 Mar 31;21(7):2416. doi: 10.3390/ijms21072416.

引用本文的文献

1
Recent Advances in Ionic Mechanisms in Pituitary Cells: Implications for Electrophysiological and Electropharmacological Research.垂体细胞离子机制的最新进展:对电生理和电药理研究的启示
J Clin Med. 2025 Apr 30;14(9):3117. doi: 10.3390/jcm14093117.
2
Evaluation of Small-Molecule Candidates as Modulators of M-Type K Currents: Impacts on Current Amplitude, Gating, and Voltage-Dependent Hysteresis.评估作为M型钾电流调节剂的小分子候选物:对电流幅度、门控和电压依赖性滞后的影响。
Int J Mol Sci. 2025 Feb 11;26(4):1504. doi: 10.3390/ijms26041504.
3
Effective Perturbations by Small-Molecule Modulators on Voltage-Dependent Hysteresis of Transmembrane Ionic Currents.

本文引用的文献

1
Evaluation of the Clinical Efficacy and Complications of Duloxetine in Comparison to Solifenacin in the Treatment of Overactive Bladder Disease in Women: A Randomized Clinical Trial.评价度洛西汀与索利那新治疗女性膀胱过度活动症的临床疗效和并发症:一项随机临床试验。
Urol J. 2021 Aug 3;18(5):543-548. doi: 10.22037/uj.v18i.6274.
2
Transcutaneous electrical nerve stimulation and solifenacin succinate versus solifenacin succinate alone for treatment of overactive bladder syndrome: A double-blind randomized controlled study.经皮电神经刺激联合琥珀酸索利那新与单用琥珀酸索利那新治疗膀胱过度活动症的双盲随机对照研究。
PLoS One. 2021 Jun 23;16(6):e0253040. doi: 10.1371/journal.pone.0253040. eCollection 2021.
3
小分子调节剂对跨膜离子电流电压依赖性滞后的有效扰动。
Int J Mol Sci. 2022 Aug 21;23(16):9453. doi: 10.3390/ijms23169453.
4
Evidence for Dual Activation of and Caused by QO-58 (5-(2,6-Dichloro-5-fluoropyridin-3-yl)-3-phenyl-2-(trifluoromethyl)-1H-pyrazolol[1,5-a]pyrimidin-7-one).证据表明 QO-58(5-(2,6-二氯-5-氟吡啶-3-基)-3-苯基-2-(三氟甲基)-1H-吡唑并[1,5-a]嘧啶-7-酮)能双重激活 和 。
Int J Mol Sci. 2022 Jun 24;23(13):7042. doi: 10.3390/ijms23137042.
Mirabegron versus Solifenacin in Children with Overactive Bladder: Prospective Randomized Single-Blind Controlled Trial.
米拉贝隆与索利那新治疗儿童膀胱过度活动症的前瞻性随机单盲对照试验
Urol Int. 2021;105(11-12):1011-1017. doi: 10.1159/000515992. Epub 2021 May 19.
4
Antimuscarinic use among older adults with dementia and overactive bladder: a Medicare beneficiaries study.老年痴呆症和膀胱过度活动症患者中抗毒蕈碱药物的使用:一项针对医疗保险受益人的研究。
Curr Med Res Opin. 2021 Aug;37(8):1303-1313. doi: 10.1080/03007995.2021.1920899. Epub 2021 May 13.
5
Editorial to the Special Issue "Electrophysiology".社论:特刊“电生理学”。
Int J Mol Sci. 2021 Mar 15;22(6):2956. doi: 10.3390/ijms22062956.
6
Use of bladder antimuscarinics is associated with an increased risk of dementia: a retrospective population-based case-control study.使用膀胱抗毒蕈碱药物与痴呆风险增加相关:一项基于人群的回顾性病例对照研究。
Sci Rep. 2021 Mar 1;11(1):4827. doi: 10.1038/s41598-021-84229-2.
7
Effective Activation by Kynurenic Acid and Its Aminoalkylated Derivatives on M-Type K Current.色氨酸代谢产物犬尿氨酸及其氨烷基衍生物对 M 型钾电流的有效激活作用。
Int J Mol Sci. 2021 Jan 28;22(3):1300. doi: 10.3390/ijms22031300.
8
Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity.索利那新在膀胱过度活动症或神经源性逼尿肌过度活动症的儿科人群中的药代动力学。
Pharmacol Res Perspect. 2020 Dec;8(6):e00684. doi: 10.1002/prp2.684.
9
Comparative risk of adverse outcomes associated with nonselective and selective antimuscarinic medications in older adults with dementia and overactive bladder.比较痴呆和膀胱过度活动症老年患者使用非选择性和选择性抗毒蕈碱药物相关不良结局的风险。
Int J Geriatr Psychiatry. 2021 May;36(5):684-696. doi: 10.1002/gps.5467. Epub 2020 Nov 18.
10
The Specific Effects of OD-1, a Peptide Activator, on Voltage-Gated Sodium Current and Seizure Susceptibility.OD-1,一种肽激活剂,对电压门控钠离子电流和癫痫易感性的特定影响。
Int J Mol Sci. 2020 Nov 4;21(21):8254. doi: 10.3390/ijms21218254.